Pertuzumab: evolving therapeutic strategies in the management of HER2-overexpressing breast cancer

By O'Sullivan Ciara C   Swain Sandra M  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 779-790

Informa Healthcare

Access to resources Recommend Favorite

Abagovomab for ovarian cancer

By Pfisterer Jacobus   Harter Philipp   Simonelli Cecilia   Peters Martin   Berek Jonathan   Sabbatini Paul   du Bois Andreas  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 3, 2011-03 ,pp. : 395-403

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy of ovarian cancer

By Kirby Tyler O   Alvarez Ronald   Huh Warner  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 4, 2002-04 ,pp. : 409-417

Informa Healthcare

Access to resources Recommend Favorite

Cellular immunotherapy for ovarian cancer

By Cannon Martin J   O'Brien Timothy J  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 6, 2009-06 ,pp. : 677-688

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal antibodies therapies for ovarian cancer

By Leone Roberti Maggiore Umberto   Bellati Filippo   Ruscito Ilary   Gasparri Maria Luisa   Alessandri Franco   Venturini Pier Luigi   Ferrero Simone  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 5, 2013-08 ,pp. : 739-764

Informa Healthcare

Access to resources Recommend Favorite